# RASONQUE

NDC: 85219-101
Generic name: daraxonrasib
Labeler / Manufacturer: Revolution Medicines, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260826

FDA application: NDA220910

## Active ingredients

- DARAXONRASIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"85219-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=85219-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13a65923-d072-4dac-8620-8eabbf8c3641